Using the Human Genome Project as her guide, she helped find genes responsible for cardiovascular disease, autism and a rare disorder called Miller syndrome.
New collaboration to study early detection of developmental differences in children
The University of Washington s School of Medicine Brotman Baty Institute for Precision Medicine is collaborating with Illumina, Inc. and GeneDx, Inc., a wholly owned subsidiary of BioReference Laboratories, Inc., an OPKO Health company, to study early detection of developmental differences in children.
The project, SeqFirst, will provide early access to whole-genome sequencing (WGS) to 100 children suspected of having developmental differences at the point of diagnosis.
Scientists anticipate this will lead to earlier, more rapid diagnoses, as well as lowering health care costs and improving subsequent treatment for these children. Illumina will support the study by providing advanced sequencing reagents and GeneDx will perform state-of-the-art diagnostic WGS.
UW School of Public Health
Graduate student Naomi Nkinsi was chosen for the Paul & Daisy Soros Fellowship for New Americans.
Naomi Nkinsi grew up in Yaoundé, Cameroon, speaking French, wearing brightly colored clothes, and her name was pronounced “Now-me.”
Her parents were from the Democratic Republic of Congo and she grew up with a rich history of African culture. But when she moved to a suburb of Atlanta when she was 6, she changed her name to “Nay-o-me” and ditched the brightly colored clothes for jeans and T-shirts. She struggled to fit in.
Nkinsi, now a third-year Global Health Pathway medical student at the University of Washington School of Medicine and public health student at the University of Washington School of Public Health, is one of 30 winners of the Paul & Daisy Soros Fellowship for New Americans. Winners get $90,000 unless graduating sooner. This is a highly competitive fellowship looking for graduate students who are going to make the most significant c